Multidrug efflux pumps, such as CmeABC and CmeDEF, are involved in the resistance of Campylobacter to a broad spectrum of antimicrobials. The aim of this study was to analyse the effects of two putative efflux-pump inducers, bile salts and sodium deoxycholate, on the resistance of Campylobacter to biocides (triclosan, benzalkonium chloride, chlorhexidine diacetate, cetylpyridinium chloride and trisodium phosphate), SDS and erythromycin. The involvement of the CmeABC and CmeDEF efflux pumps in this resistance was studied on the basis of the effects of bile salts and sodium deoxycholate in Campylobacter cmeB, cmeF and cmeR mutants. The genetic variation in the cmeB gene was also examined, to see whether this polymorphism is related to the function of the efflux pump. In 15 Campylobacter jejuni and 23 Campylobacter coli strains, bile salts and sodium deoxycholate increased the MICs of benzalkonium chloride, chlorhexidine diacetate, cetylpyridinium chloride and SDS, and decreased the MICs of triclosan, trisodium phosphate and erythromycin. Bile salts and sodium deoxycholate further decreased or increased the MICs of biocides and erythromycin in the cmeF and cmeR mutants. For cmeB polymorphisms, 17 different cmeB-specific PCR-RFLP patterns were identified: six within C. jejuni only, nine within C. coli only and two in both species. In conclusion, bile salts and sodium deoxycholate can increase or decrease bacterial resistance to structurally unrelated antimicrobials. The MIC increases in the cmeF and cmeR mutants indicated that at least one non-CmeABC efflux system is involved in resistance to biocides. These results indicate that the cmeB gene polymorphism identified is not associated with biocide and erythromycin resistance in Campylobacter.
INTRODUCTION
The thermotolerant Campylobacter spp., and especially Campylobacter jejuni and Campylobacter coli, are the most commonly reported bacterial causes of foodborne gastroenteritis in humans worldwide. These bacteria are usually transmitted through contaminated food and drinking water (Moore et al., 2006) . As well as their widespread occurrence, Campylobacter spp. have become increasingly resistant to antibiotics. The mechanisms of antibiotic resistance are generally well known. In contrast to antibiotics, which are considered to have an activity against only one major target site, biocides have a broad spectrum of activity and can act at several target sites in bacterial cells (Russell, 2002) . A potential concern is the possibility that mechanisms that provide resistance to biocides might also provide cross-protection against the activities of antibiotics (Meyer & Cookson, 2010) .
Active efflux mechanisms are responsible for the transportation of a wide range of toxic compounds out of the cell, and these can provide a multidrug resistance (MDR) phenotype in many bacteria (Li & Nikaido, 2004; Amaral et al., 2007) . The major resistance-nodulation-cell division (RND) efflux system, CmeABC, is essential for Campylobacter colonization in animal intestines through its mediation of bile-salt resistance (Lin et al., 2002) . CmeABC has been demonstrated to contribute to resistance to a broad range of antimicrobials in Campylobacter (Martinez & Lin, 2006) . The expression of this efflux pump is under the control of a transcriptional repressor, CmeR, which binds directly to the cmeABC promoter (Lin et al., 2005a) . CmeR is induced by the natural substrates of this efflux pump, bile salts, which can interact directly with CmeR, leading to its reduced binding to the promoter and increased transcription of the efflux genes (Lin et al., 2005b) . Mutations in the repressor or repressor-binding sequences can result in overexpression of the efflux pump, which can increase bacterial resistance to structurally unrelated antimicrobials (Lin et al., 2002 (Lin et al., , 2005a Li & Nikaido, 2004) .
A second RND efflux system, known as CmeDEF, that is functionally distinct from CmeABC has been identified in Campylobacter (Akiba et al., 2006) . As the C. jejuni genome contains at least eight other non-RND efflux pumps, these might also be involved in the extrusion of toxic compounds and might also mediate MDR (Pumbwe et al., 2005) . Indeed, the CmeGH multidrug efflux transporter from the major facilitator family has been demonstrated recently to contribute to antibiotic resistance in C. jejuni (Jeon et al., 2011) .
The involvement of efflux mechanisms in bacterial intrinsic and acquired resistance has been demonstrated mostly by the use of efflux-pump inhibitors (EPIs), such as 1-(1-naphthylmethyl)-piperazine (NMP) and the competitive inhibitor phenylalanine-arginine b-naphthylamide (PAbN). These EPIs enhance drug accumulation inside the bacterial cell, thereby increasing the bacterial susceptibility to antimicrobials (Kern et al., 2006; Martins et al., 2009b; Mavri & Smole Možina, 2012) . Similarly, the use of effluxpump inducers, such as bile salts, can induce the expression of efflux genes (Hannula & Hänninen, 2008) .
The aim of the present study was to analyse the effects of bile salts and sodium deoxycholate on the susceptibility of C. jejuni and C. coli to a broad range of biocides: triclosan (TLN), benzalkonium chloride (BC), cetylpyridinium chloride (CPC), chlorhexidine diacetate (CHA) and trisodium phosphate (TSP). Mutants of C. jejuni strain NCTC 11168 that lacked the cmeB and cmeF genes, which code for the inner membrane efflux transporters, and a cmeR mutant were screened. As biocide resistance might be responsible for the selection of antibiotic-resistant bacteria, and as efflux mechanisms can contribute to MDR, the involvement of active efflux in resistance to the clinically important antibiotic erythromycin was also examined, along with the anionic surfactant SDS, which is added to a wide range of cleaning agents to assist in cleaning (Smulders et al., 2002) . In addition, genetic variation in the cmeB gene was examined to see whether this polymorphism affects the function of the transporter component of the CmeABC efflux pump, and thereby the antimicrobial resistance in Campylobacter.
METHODS
Bacterial strains and growth conditions. Fifteen C. jejuni and 23 C. coli strains isolated from animals (poultry and pigs), humans and the environment (surface waters) were used in this study. The cultures were stored at 280 uC in brain-heart infusion broth (Biolife) with 20 % horse blood (Oxoid) and 20 % glycerol (Kemika). The isolates were cultivated at 42 uC under microaerophilic conditions (3 % O 2 , 10 % CO 2 and 87 % N 2 ) in gas-tight containers on Karmali or Columbia agar supplemented with 5 % horse blood (Oxoid). The reference strains used were: C. jejuni NCTC 11168, C. jejuni ATCC 33560 and C. coli ATCC 33559. Knockout cmeB (Lin et al., 2002) , cmeF (Akiba et al., 2006) and cmeR (Lin et al., 2005b ) mutants of C. jejuni NCTC 11168, constructed previously in our laboratory (Klančnik et al., 2012) , were also used.
Antimicrobial susceptibility testing. The MICs of TLN (Merck), BC, CHA, CPC and TSP (Sigma-Aldrich), SDS (Invitrogen) and erythromycin (Sigma-Aldrich) were determined using the broth microdilution method, as described previously (Mavri & Smole Možina, 2012) . Assays were repeated twice, each in duplicate, to confirm the reproducibility of the MIC data. Erythromycin resistance breakpoints were defined according to the recommendations of the Clinical Laboratories Standards Institute (CLSI, 2007) . C. coli ATCC 33559 and C. jejuni ATCC 33560 and NCTC 11168 reference strains were used as the erythromycin susceptibility test controls.
Effects of bile salts and sodium deoxycholate. The MICs of the five biocides (TLN, BC, CPC, CHA and TSP) and of SDS and erythromycin were determined using the broth microdilution method, as described above, in the presence of bile salts and sodium deoxycholate. For this purpose, Mueller-Hinton broth was supplemented with a mixture of bile salts extracted from purified fresh bile (Fluka) or with sodium deoxycholate (Sigma-Aldrich) to final concentrations of 2 mg ml
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. Preliminary microdilution tests showed that atz a concentration of 2 mg ml
, bile salts and sodium deoxycholate alone had no inhibitory effects on the bacterial growth of these strains, with the exception of C. coli strain VC7114 and the cmeB mutant. These last two strains were thus not included in further tests.
Analysis of the cmeB gene polymorphism by PCR-RFLP. PCR-RFLP was used to study the cmeB polymorphism, using a method published previously (Cagliero et al., 2006) , with a few modifications. Genomic DNA was extracted using a QIAamp DNA Mini kit (Qiagen). The primers cmeA1078Fwd (59-GAAGTTAAAGAAATTGGAGCA-CAATAA-39) and cmeC47Rev (59-TGGACTTAAAGAGCAAGCTGA-AA-39) were used to amplify a 3213 bp fragment. The cmeB amplicons were analysed using the following restriction enzymes and combinations: HindIII, PvuII, HaeII, XmnI, EcoRV, EcoRI, PstI, BsmAI, HindIII/ PvuII, PvuII/XmnI, HindIII/HaeII and EcoRI/PstI. The fragments were separated on 2.5 % agarose gels. The molecular sizes of the digests were determined by comparison with a molecular marker (GeneRuler DNA Ladder Mix; Fermentas) using Quantity One 1-D Analysis software, version 4.0.3 (Bio-Rad). Restriction maps of the PCR-amplified cmeB gene in the Campylobacter strains with unknown cmeB sequence were determined by comparison of the restriction patterns of the C. jejuni NCTC 11168 and C. coli ATCC 33559 cmeB genes with known sequences and with the restriction patterns of the C. jejuni and C. coli cmeB genes published by Cagliero et al. (2006) . The cmeB sequences were obtained from GenBank. AcaClone pDRAW32 DNA Analysis software, version 1.1.107, was used to create the virtual agarose electrophoresis gels and restriction maps with the exact restriction sites.
Detection of the A2075G mutation in the 23S rRNA gene by PCR-RFLP. PCR-RFLP was used to detect the A2075G mutation of the 23S rRNA gene, as described previously (Leser et al., 1997; Kurinčič et al., 2007) , which is associated with erythromycin resistance. The primers Ery23SFwd (59-GTAAACGGCCGTAACTA-39) and Ery23SRev (59-GACCGAACTGTCTCACGACG-39) were used to amplify a 714 bp fragment. The 23S rRNA amplicons were digested with the restriction enzyme BsmAI and the fragments separated on 2.5 % agarose gels. The molecular sizes of the digests were determined by comparison with a molecular marker (PCR 20 bp Low Ladder; Sigma) using Quantity One 1-D Analysis software, version 4.0.3.
Statistical analysis. Statistical analyses were performed with IBM PASW Statistics software, version 18.0. The MICs from the antimicrobial assays and the effects of bile salts and sodium deoxycholate were compared using independent-sample t-tests to determine the significance of the differences in resistance between C. jejuni and C. coli, and between the erythromycin-sensitive and -resistant strains. The correlation of antimicrobial MICs distributions and the effects of bile salts and sodium deoxycholate were compared using Pearson's x 2 test. Analysis of variance (ANOVA) was used to determine the significance of the differences between the strains with different cmeB restriction patterns for resistance and the effects of the bile salts and sodium deoxycholate, and of the EPIs PAbN and NMP, as determined in our previous study (Mavri & Smole Možina, 2012) . Pearson coefficients were calculated for the correlation matrix between the MICs and the effects of the EPIs, bile salts and sodium deoxycholate. Two-tailed P values were determined, and the results were considered significant when P¡0.05.
RESULTS

Antimicrobial susceptibility
In total, 38 animal, human and environmental water C. jejuni and C. coli isolates were tested for susceptibility to the five biocides TLN, BC, CPC, CHA and TSP, and to the anionic surfactant SDS and the antibiotic erythromycin. The ranges of the MICs (in twofold increases) are given in Table 1 and the results from the MIC tests in Table 2 .
With regard to erythromycin resistance, 28 of the 38 strains tested (73.7 %) were susceptible (MIC ,8 mg ml 21 ) and ten (26.3 %) were resistant (MIC ¢32 mg ml
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). There were no statistically significant differences in resistances to the biocides and SDS among these erythromycin-sensitive and -resistant strains, or between C. jejuni and C. coli (t-test, P.0.05).
A Pearson correlation matrix was calculated for the distribution of MICs of the biocides and of SDS and erythromycin. There were statistically significant correlations between the MIC distributions of BC and CPC (P50.000, r xy 50.594), CPC and CHA (P50.002, r xy 50.482), TSP and SDS (P50.000, r xy 50.578) and BC and erythromycin (P50.028, r xy 50.357). There were no other statistically significant correlations between the MICs of erythromycin and the other biocides tested.
The erythromycin resistance data determined in our previous study (Mavri & Smole Možina, 2012) were largely different from those obtained in the present study. An instability of resistance to biocides and SDS was also observed. These instabilities are given in Table 1 . The greatest erythromycin MIC increase occurred in C. jejuni strains 850 and 1845 (1024-and 2048-fold, respectively), which switched from initially sensitive phenotypes (MICs of 0.25 and 0.5 mg ml
, respectively) to resistant phenotypes (MIC of 512 mg ml 21 for both).
Effects of bile salts and sodium deoxycholate
The efficiencies of bile salts and sodium deoxycholate were determined in terms of the bacterial resistance to the five biocides TLN, BC, CPC, CHA and TSP, and to SDS and erythromycin. The MICs from these experiments are presented in Tables 2 and 3 .
Bile salts and sodium deoxycholate increased the BC, CPC, CHA and SDS resistance in a large proportion of the tested strains, with one exception (an SDS MIC decreased instead of increasing) (Table 3) . Conversely, the MICs of TLN, TSP and erythromycin were reduced, with a few exceptions (some TLN and TSP MICs increased instead of decreasing) (Table 3) . Differences in the effects of bile salts and sodium deoxycholate were seen between C. jejuni and C. coli. The bile salts had greater effects on the resistance to BC and CHA in C. jejuni than in C. coli (t-test, P50.009 and P50.019, respectively), whilst both bile salts and sodium deoxycholate had greater effects on TSP susceptibility in C. coli than in C. jejuni (t-test, P50.004 and P50.014, respectively) ( Table 2) . A Pearson correlation matrix was calculated for the distribution of the effects of both bile Table 1 . MIC ranges from the present study and a previous study (Mavri & Smole Možina, 2012) , and the MIC changes in these Campylobacter strains Antimicrobial MIC (mg ml Of note, the greatest MIC reduction in the presence of bile salts and sodium deoxycholate occurred in C. jejuni strain 850, in terms of erythromycin resistance (512-and 1024-fold MIC decreases, respectively), which resulted in loss of the resistance phenotype, whilst this was not the case in C. jejuni strain 1845.
The effects of cmeB, cmeF and cmeR gene inactivation on the antimicrobial resistance in the C. jejuni NCTC 11168 strain determined in our previous study (Mavri & Smole Možina, 2012) , and the effect of bile salts and sodium deoxycholate addition in these mutant strains, are given in Table 4 . In the cmeF mutant, bile salts and sodium deoxycholate increased the MICs of BC, CPC, CHA and SDS (from four-to 64-fold), and sodium deoxycholate increased the MIC of erythromycin (fourfold). Also in this cmeF mutant, the MIC of TLN was reduced by the bile salts and sodium deoxycholate (eight-and fourfold, respectively) and the TSP MIC was reduced by sodium deoxycholate (twofold). Moreover, in the cmeR mutant, bile salts and sodium deoxycholate increased the resistance to BC, CPC, CHA and SDS (two-to 64-fold MIC increases). The TLN MIC was reduced by both bile salts and sodium deoxycholate in this cmeR mutant (four-and twofold, respectively) and the MICs of erythromycin and TSP were reduced by sodium deoxycholate (twofold). The cmeB mutant strain showed sensitivity to bile salts and sodium deoxycholate at a concentration of 2 mg ml
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. Therefore, neither of the efflux-pump inducers was tested for their effects on the resistance in this strain.
PCR-RFLP analysis of the cmeB polymorphism PCR-RFLP was used to study the cmeB gene polymorphism. Restriction maps of the PCR-amplified cmeB gene in the 32 Campylobacter strains examined are given in Fig. 1 . Thirteen different cmeB-specific PCR-RFLP patterns were defined among these 32 tested strains. Restriction maps with the exact restriction sites were not determined for five C. jejuni water isolates (653, 807, 850, 2782 and 1845) and one C. coli (652/1) water isolate, due to the high diversities of the restriction sites. The restriction sites for three restriction enzymes (HindIII, PvuII and XmnI) in these strains differed from the restriction patterns of all cmeB genes with known sequence that were used for comparison in this study (Fig. 2) . However, on the basis of the lengths of the restriction digests, we defined four additional PCR-RFLP patterns among these six Campylobacter strains, numbered as follows: 14, for C. jejuni strains 653 and 807; 15, for C. jejuni 850; 16, for C. jejuni 2782 and 1845; and 17, for C. coli 652/1. Therefore, overall, 17 different cmeB PCR-RFLP patterns were identified among the 38 strains tested. Six of these patterns were characteristic for C. jejuni and nine for C. coli, and two restriction patterns were found in both species.
The impact of genetic variation in the cmeB gene on resistance and efflux
The impact of sequence variation of the cmeB transporter on its function was analysed by comparisons of the resistance levels and the effects of bile salts and sodium deoxycholate, as well as through the effects of the EPIs PAbN and NMP (Mavri & Smole Možina, 2012) , among the Campylobacter strains with different PCR-RFLP patterns (ANOVA test). The instability of the resistances that appeared from our previous antimicrobial tests (Mavri & Smole Možina, 2012) was included in these comparisons as well.
Mean MIC changes for observed statistically significant differences between strains with different cmeB-specific PCR-RFLP patterns are presented in Fig. 3 . According to ANOVA tests, between the strains with different cmeBspecific PCR-RFLP patterns, there were no statistically significant differences in the resistances to the five biocides or to SDS and erythromycin (P.0.05). The MICs from this and our previous study (Mavri & Smole Možina, 2012) were included in this analysis. However, considering again these strains with different cmeB-specific PCR-RFLP patterns, there were statistically significant differences in the instability of resistance to BC and erythromycin (P50.000) (Fig.  3a ). There were also statistically significant differences in the effects of the bile salts on resistance to BC and erythromycin (P50.016 and P50.000, respectively), and for the effects of sodium deoxycholate on resistance to CPC and erythromycin (P50.041 and P50.000, respectively) (Fig. 3b, c) . Moreover, there were statistically significant differences in the effects of PAbN on erythromycin resistance (P50.032) and of NMP on resistance to CPC (P50.02) (Fig. 3d) . Interestingly, the highest erythromycin change in MIC occurred in C. jejuni strain 850 with restriction pattern no. 15 (see Fig. 3a ), where we also observed the greatest effects of the two putative efflux-pump inducers (Fig. 3b, c) . However, no other characteristic links between these differences in these strains with different cmeB-specific PCR-RFLP patterns could be seen from the data shown in Fig. 3 .
Target mutation in the 23S rRNA gene PCR-RFLP was used to test for the presence of the A2075G mutation in the 23S rRNA gene. Eight of ten tested Campylobacter strains that belonged to the erythromycinresistant group had the A2075G mutation (Table 2) . Conversely, the A2075G mutation was not identified in two erythromycin-resistant C. jejuni strains (850 and 1845), nor in any of the erythromycin-sensitive strains.
DISCUSSION
In this study, we have highlighted the role of efflux mechanisms in biocide resistance of Campylobacter through Effects of efflux-pump inducers in biocide resistance Effects of efflux-pump inducers in biocide resistance 
*The presence of the A2075G mutation in the 23S rRNA gene was confirmed in these strains. *Number of strains (n)/number of tested Campylobacter strains (N).
A. Mavri and S. Smole Možina
the use of bile salts and sodium deoxycholate. Both of these increased the BC, CPC, CHA and SDS resistances in a high proportion of the tested strains, although this was not the case for TLN, TSP and erythromycin resistance. It has been shown previously that bile salts (such as cholate, deoxycholate and taurocholate) can increase the resistance of C. jejuni to several structurally diverse antimicrobials (Lin et al., 2005b) . However, cholate did not cause any measurable erythromycin and ciprofloxacin MIC changes. A small effect of sodium deoxycholate on the resistance to several antibiotics was also reported by Hannula & Hänninen (2008) . Our observations of the different effects of bile salts related to resistance to structurally diverse antimicrobials are therefore consistent with those of previous studies, although the reasons for these different effects are as yet unclear. The results presented here and the observations of our previous study (Mavri & Smole Možina, 2012) about the effects of the EPIs PAbN and NMP on the resistance to these different antimicrobials indicate that active efflux mechanisms have distinct roles in susceptibility to antimicrobials from diverse classes, which might be related to their different mechanisms of action. On the basis of restored sensitivity in the presence of EPIs that block different types of efflux pumps, it has been shown previously that more than one type of active efflux is involved in bacterial resistance to dissimilar biocides (Braoudaki & Hilton, 2005) . Another possible explanation is that different antimicrobials might compete with each other for the binding sites on the efflux pumps (Kern et al., 2006; Martins et al., 2009b) . The presence of one antimicrobial agent, such as bile salts or sodium deoxycholate, that binds to the efflux pump more successfully than another might therefore lead to increased susceptibility to other antimicrobials.
However, the highest erythromycin MIC reduction in the presence of bile salts occurred in the erythromycinresistant C. jejuni 850 strain, which did not carry the A2075G mutation in the 23S rRNA and showed a sensitive phenotype in our first tests (Mavri & Smole Možina, 2012) .
No mutations for erythromycin-resistant Campylobacter strains have been published recently by others (Gibreel et al., 2005; Kurinčič et al., 2007) . Other studies have also reported unstable erythromycin resistance phenotypes: Campylobacter mutants that show low-to-intermediate levels of erythromycin resistance and that lack 23S rRNA mutations were not stable in culture medium or on the animal host, and they easily lost their resistance phenotype in the absence of macrolide antibiotics (Kim et al., 2006; Caldwell et al., 2008; Luangtongkum et al., 2009) . In contrast, bile salts had no effect on erythromycin resistance in C. jejuni strain 1845, whilst its resistance phenotype increased from sensitive in our first tests to resistant. The induction of cmeB and cmeF efflux genes in the presence of subinhibitory concentrations of bile salts and erythromycin was also assessed with real-time PCR in our laboratory and reported recently by Kurinčič (2011) . In this investigation, seven strains, also used in the present study, were included: three C. coli poultry isolates (137, 140 and K33/1), three C. coli animal isolates (VC7114, VC110722 and VC110725) and the reference strain ATCC 33559. A strain-specific response of induction of the selected genes was observed.
Comparison of the erythromycin resistance phenotype of tested C. coli isolates and their induction of the efflux genes showed no correlation. Our results are therefore consistent with those of the previous study.
In this study, we also noted the instability of biocide resistance in comparison with our previous tests (Mavri & Effects of efflux-pump inducers in biocide resistance in restoration of the activity of genes that regulate and code for the efflux pump transporters. This restoration was accompanied by a continued progressive increase in resistance to antibiotics and by the inability of the strain to revert in drug-free medium to the initial antibiotic susceptibility, which suggest that exposure of the bacteria to an environment that remains constantly noxious leads to the response of the genetic system of the organism to activate a mutator system, which results in the accumulation of mutations that render the organism MDR (Chopra et al., 2003; Martins et al., 2009a) . The accumulation of these mutations, accompanied by restoration of efflux to baseline levels, enables the organism to reduce energy consumption, as overexpressed efflux pump systems consume a large amount of metabolic energy as the main source of the proton-motive force, along with the maintained MDR phenotype (Martins et al., 2009a) . High genetic heterogeneity, accumulation of mutations and the restoration of efflux activity might also be an explanation for the appearance of enhanced tolerance to biocides and the acquired erythromycin resistance in C. jejuni strains 850 and 1845, not mediated by chromosomal mutation, found in this study.
The involvement of two major RND efflux systems, CmeABC and CmeDEF, in the antimicrobial resistance in Campylobacter was studied on the basis of the effects of bile salts and sodium deoxycholate in cmeF and cmeR mutants. The MICs in these mutants increased, which confirmed that at least two of the efflux systems, CmeABC and CmeDEF, are involved in this biocide resistance. The simultaneous activity of different efflux pumps, along with genetic heterogeneity and potential activation of a mutator system, might also explain the differences in the effect of bile salts on erythromycin resistance in C. jejuni 850 and 1845 strains. It has also been demonstrated that efflux systems of Gram-negative bacteria might be significantly affected by the pH of the environment through the disruption of the proton-motive force (Amaral et al., 2011) , and that low pH readily activates RND efflux genes in E. coli and renders the organism resistant, as well as the fact that high pH activates the ATP-binding cassette transporter (Martins et al., 2009b) . The effect of pH on antimicrobial and biocide resistance is a subject of interest for further investigation and would contribute to a better understanding of the efflux mechanisms in Campylobacter.
Large genetic variation was seen in this study for the multidrug transporter cmeB gene in C. jejuni and C. coli. The cmeB gene polymorphism in C. jejuni and C. coli has also been reported previously (Cagliero et al., 2006) . However, a link between this polymorphism and the function of this multidrug transporter has not yet been demonstrated. It was suggested by Cagliero et al. (2006) that this polymorphism might be related to the overall high genetic diversity found in these bacteria, and that the CmeB transporter can thus tolerate sequence variations without being impaired in its function. Statistically significant differences in the instabilities of resistance to BC and erythromycin in strains with different cmeB-specific PCR-RFLP patterns were noted. In addition, the effects of bile salts, sodium deoxycholate and EPIs (Mavri & Smole Možina, 2012 ) on resistance to BC, CPC and erythromycin also differed among these strains. These observations suggest that the genetic polymorphism in these multidrug transporters is somehow associated with Fig. 2 . Restriction fragments of the 13 different cmeB-specific PCR-RFLP patterns of the cmeB gene of the two reference strains (C. jejuni NCTC 11168 and C. coli ATCC 33559), five C. jejuni strains (653, 807, 850, 2782 and 1845) and one C. coli strain (652/1) after HindIII (a), PvuII (b) and XmnI (c) digestion.
Effects of efflux-pump inducers in biocide resistance their function. However, these differences in the resistance instability and the effects on efflux of bile salts, sodium deoxycholate and the EPIs did not appear to be associated, with the exception of restriction pattern no. 15, which belonged to C. jejuni strain 850 (Fig. 3) . Modifications to this multidrug transporter and their impact on its function are thus unique to each strain of Campylobacter. However, this comparison only provided us with a raw assessment of the impact of the sequence variations in the cmeB gene on the function of its protein product, as nine out of 17 cmeBspecific PCR-RFLP patterns determined (.50 %) were represented by only one Campylobacter strain. The impact of the genetic variations of the CmeB transporter on its function and substrate recognition of the efflux pump will therefore be of interest for further investigation. 
